NCT01755559View on ClinicalTrials.gov

Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi Niger

PHASE4CompletedINTERVENTIONAL
Enrollment

663

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Malaria
Interventions
DRUG

Artesunate-amodiaquine

antimalarial ACT

DRUG

Dihydroartemisinin-piperaquine

antimalarial ACT

DRUG

Artemether-lumefantrine

antimalarial ACT

Trial Locations (1)

Unknown

Andoumé Health Centre, Maradi

Sponsors

Lead Sponsor

Epicentre
All Listed Sponsors
collaborator

Centre de Recherche Médicale et Sanitaire (Cermes), Niamey

UNKNOWN

lead

Epicentre

OTHER